Recherche
-
Correction to: Evolution of body composition following successful kidney transplantation is strongly influenced by physical activity: results of the CORPOS study
(BMC Nephrology. vol. 22, n° 1, 2021-02-16)Article de revueLibre accès -
Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals
(Frontiers in Immunology. vol. 10, 2019-04-24)Article de revueLibre accès -
mTOR Inhibitors Prevent CMV Infection through the Restoration of Functional αβ and γδ T cells in Kidney Transplantation.
(Journal of the American Society of Nephrology. vol. 33, n° 1, 2022-01)Article de revueLibre accès -
Ebola vaccine development: Systematic review of pre-clinical and clinical studies, and meta-analysis of determinants of antibody response variability after vaccination
(International Journal of Infectious Diseases. vol. 74, pp. 83-96, 2018-09)Article de revueLibre accès -
The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa)
(Journal of the International AIDS Society. vol. 21, n° Suppl 4, pp. e25128, 2018-07)Article de revueLibre accès -
A randomized placebo-controlled efficacy study of a prime boost therapeutic vaccination strategy in HIV-1 infected individuals: VRI02 ANRS 149 LIGHT Phase II trial
(Journal of Virology, 2021-02-10)Article de revueLibre accès -
Long-lasting severe immune dysfunction in Ebola virus disease survivors
(Nature Communications. vol. 11, n° 1, pp. 3730, 2020)Article de revueLibre accès -
Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa
(Journal of the International AIDS Society. vol. 22, n° 10, pp. e25402, 2019-10)Article de revueLibre accès -
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine
(EBioMedicine. vol. 80, 2022-06)Article de revueLibre accès -
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
(Lancet Global Health. vol. 11, n° 11, pp. e1743-e1752, 2023-11)Article de revueLibre accès